Issues for new antiepilepsy drug development

Michele Simonato; Jacqueline A French; Aristea S Galanopoulou; Terence J O'Brien

Journal article

Issues for new antiepilepsy drug development

Michele Simonato, Jacqueline A French, Aristea S Galanopoulou, Terence J O'Brien

Current Opinion in Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2013

DOI: 10.1097/WCO.0b013e32835efe29

University of Melbourne Researchers

Terry O'Brien Author Medicine and Radiology

Grants

Awarded by NINDS

Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

Funding Acknowledgements

The support of the International League Against Epilepsy (ILAE), American Epilepsy Society (AES), Citizens United for Research in Epilepsy (CURE), Autism Speaks and Epilepsy Therapy Project for the London workshop on optimization of preclinical epilepsy therapy discovery is gratefully acknowledged by all authors. We would also like to acknowledge the participants of the London workshop for their valuable input. A.S.G. has received research grant support by NINDS NS078333, NS020253, Autism Speaks, CURE, the Heffer Family Foundation, and the Siegel family Foundation.